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(Under the direction of Carrie Palmer) 
Purpose: The goal of this project was to help create a sustainable infrastructure for 
treatment of substance use disorder (SUD) by evaluating a newly developed program that 
educates future prescribers on the urgency and inequity of access to substance use disorder 
treatment.  This program is offered though Mountain Area Health Education Center (MAHEC) 
in Asheville, North Carolina and is titled, Intersection: Promoting Equity in the Management of 
(SUDs) with a focus on Opioid Use Disorder (OUD). 
Background: Individuals who live in rural areas and marginalized communities are more 
vulnerable to overdose because they lack the necessary resources to assist with opioid use 
treatment.  A major contributing factor to this problem is the lack of providers with MAT 
waivers in these disadvantaged communities.   
Methods: A post- survey questionnaire was offered immediately after the online program 
through the platform Survey Monkey.  
Results/ outcomes:  The anticipated results from the post- survey questionnaire were 
increased provider willingness to learn more about becoming a MAT waivered provider, 
increased awareness of the inequities that surround SUD treatment and increased interest to serve 
historically marginalized or rural communities.  
Implications/ conclusions: The results revealed promising information into the 
development of this program.  The majority of respondents gained insight, knowledge and 
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increased interest into working with individuals with SUD in historically marginalized 
communities.  All anticipated outcomes were successfully achieved.   
Key Words: Equity, opioid use disorder, substance use disorder, medication-assisted 
treatment, marginalized/ rural communities. 
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To the Lumbee Tribe, my hope is that providers will be inspired to give equitable, empathetic 
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CHAPTER 1: INTRODUCTION  
 In order for providers to practice opioid dependency treatment with Food and Drug 
Administration (FDA) approved buprenorphine medications, the provider must receive specific 
training and apply to the Center for Substance Abuse Treatment to receive a waiver (SAMHSA, 
2019).  There is a severe national shortage of health care providers with medication-assisted 
treatment (MAT) waivers (Salvador, 2019).  Despite national efforts to increase MAT in rural 
and other historically marginalized communities, these communities lack the needed resources to 
assist with opioid use treatment (Dunn et al., 2016; Moore, Andrilla & Patterson, 2019).  Rural 
populations across the country have poorer access to substance use treatment services than urban 
communities, especially MAT treatment for opioid users.  The lack of MAT perpetuates the 
cycle of devastating effects from the opioid epidemic in rural and historically marginalized 
communities. Overdose rates among rural opioid users are higher than those who live in urban 
areas and opioid users in rural communities severely lack knowledge regarding key factors 
related to overdose (Dunn et al., 2016).  A major factor contributing to this problem is the lack of 
health care providers in rural areas with MAT waivers.  Less than half of all rural counties and 
less than a quarter of the most remote rural countries have a provider with a MAT waiver 
(Patterson, Andrilla, Larson & Moore, 2019).  Rural opioid users who successfully find waived 
providers in their community face increased barriers because of the extended waiting lists.  Many 
MAT waived providers in rural communities are at capacity to treat because of the increased 
demand and the limited MAT availability, which in turn create lengthy waiting lists.  Increasing 
education opportunities for rural providers to receive MAT waiver hours may increase MAT in 
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rural areas (Andrilla, Moore, Patterson & Larson, 2019; Sigmon, 2014).  Creating sustainable 
infrastructure to educate each future generation of prescribers on the urgency and inequity of 
access to treatment will hopefully encourage them to seek further MAT training to ultimately 
receive their waiver to prescribe buprenorphine. 
Local Context 
 In attempts to increase primary care providers with MAT waivers, the North Carolina 
Department of Health and Human Services Injury and Violence Branch (NCDHHS) has 
contracted with Mountain Area Health Education Center (MAHEC) in Asheville, North Carolina 
to create the Increasing Workforce Capacity for Medication- Assisted Treatment Through 
Residency and Advanced Practitioner Programs.  The aim of this project is to increase the 
workforce for MAT through medical residency programs and advanced practice programs to 
provide trainings and mentorships to bridge the gap in opioid disorder treatment and prevention 
in the state of North Carolina (MAHEC, 2019).  Increasing the workforce capacity to prescribe 
buprenorphine by sustainably embedding MAT related education into provider curriculums can 
help increase substance use treatment in marginalized communities. To date, the project has 
provided training to 29 residencies, seven physician assistant programs and one nurse 
practitioner program.  Thus far, the program has reached 29 of the 61 North Carolina residency 
programs in family medicine, internal medicine, psychiatry, emergency medicine, pediatrics and 
urology.  Since the beginning of this project, 1,701 providers have been trained through August 
2019 (NCDHHS, 2019).  Now in grant cycle two- as a continuation project, the Mountain Area 
Health Education Center’s Medication- Assisted Treatment Training Project has created a new 
Continuing Medical Education (CME) program titled, Intersection: Promoting Equity in the 
Management of Substance Use Disorders to educate providers in North Carolina about the health 
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inequities related to the clinical management of SUDs with a focus on opioid use disorder.  This 
program aims to address the health disparities of individuals with SUD who are from historically 
marginalized communities through an anti-oppresion intervention. This intervention examines 
concepts of structural oppression, unconscious bias, and stigma and how these problems interfere 
with providing quality care for individuals with substance use disorders (SUDs).  Through this 
program, participants examine the underlying stigma and bias associated with SUDs and treating 
individuals with SUDS and identify means to promote equitable and inclusive substance use 
treatment (NCDHHS, 2020).  
Purpose Statement  
 The purpose of this online program evaluation was to determine if participants have an 
increased interest in learning more about becoming a MAT waivered provider and if they have 
an increased interest to serve historically marginalized communities.  The intended outcomes 
were increased awareness about the limited mental health services in historically marginalized 
communities and an increased number of providers who intentionally want to embed equity 
when treating individuals with SUDs, especially opioid use disorder.  A secondary outcome was 
increased participant confidence and competence in providing equitable and inclusive care for 
individuals with SUDs. This project helps create a sustainable infrastructure for treatment of 
substance use disorder (SUD) by evaluating a newly developed program that educates future 
prescribers on the urgency and inequity of access to substance use disorder treatment.
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CHAPTER 2: BACKGROUND 
 Opioids have analgesic and central nervous system depressant effects which are used to 
manage pain.  However, when opioids are misused or abused they have the potential to cause 
euphoria.  Characteristics of opioid use disorder typically include misuse of prescribed 
medications, use of diverted opioids, or use of illicitly obtained opioids such as heroin (Strain, 
2019).  Opioid-related overdose deaths continue rise in the United States with more than 702,000 
opioids associated deaths from 1999-2017 (CDC, 2018).  In 2017 approximately 70,000 people 
died from opioid overdoses, making it a leading cause of injury- related death in the United 
States (CDC, 2018).  The rate of opioid drug overdose related deaths has increased nearly six 
times from 1999- 2018 (CDC, 2020).  The rising death rate can be outlined in three waves, the 
excessive opioid prescribing in the 1990s, the increase in heroin use in 2010, and the 
involvement of synthetic opioids in 2013 (CDC, 2018).  Opioid misuse and abuse occur for 
various reasons such as unauthorized self- medication of pain or mood, desire for euphoria, 
compulsive use due to addiction or illegal diversion for financial gain.  Risk factors for behaviors 
that might indicate an opioid use disorder include, exaggeration of pain, unclear etiology of pain, 
poor social support, psychological stress, trauma or disease (Webster, 2017).  More men die from 
opioid overdose annually compared to women and most overdoses occur between ages 16-45 
years. (McCarberg, 2015).  Persons living in rural areas are more vulnerable to overdose-related 
to prescription pain medication than those living in larger cities. Overdose rates are almost 
double in rural areas compared to their urban counterparts.  Opioid use disorder is also increased 
in economically depressed communities (McCarberg, 2015). 
 
5 
 According to the  Diagnostic and Statistical Manual of Mental Health Disorders, the 
diagnosis of opioid use disorder must pertain to a problematic pattern of opioid use leading to 
clinically significant impairment of distress, as manifested by at least two of the 11 criteria 
(APA, 2013).  The disorder can be classified as mild (two to three criteria), moderate (four to 
five), or severe (six or more).  Further diagnostic specifications can include whether and to what 
degree the disorder is in remission and if the patient is on maintenance therapy (APA, 2013).  
 Medication assisted treatment relieves the withdrawal symptoms and psychological 
cravings that cause chemical imbalances in the body to help aid in recovery and abstinence from 
opioids.  Such programs provide a safe and controlled level of medications such as methadone, 
buprenorphine and naltrexone to overcome the use of the abused opioid (SAMHSA, 2019). 
These medications treat opioid dependence and addiction by replacing short- acting and semi-
synthetic opioids like heroin, morphine, codeine, oxycodone and hydrocodone.  People can 
safely take medications provided through MAT programs for months, years or even a lifetime to 
refrain from opioid use (SAMHSA, 2019).  
 The DATA 2000 waiver, also called a MAT waiver authorizes providers to prescribe and 
dispense narcotic medications like buprenorphine in settings other than opioid treatment 
programs (SAMHSA, 2019).  The DATA 2000 waiver is part of the Children’s Health Act, 
which allows providers such as physicians, nurse practitioners and physician assistants, who 
have an active Drug Enforcement Administration (DEA) number to dispense controlled 
substances (SAMHSA, 2019).  Advanced practicing providers such as, nurse practitioners and 
physician assistants are required to obtain no fewer than 24 hours of training and physicians are 
required at least eight training hours provided by an organization that the Secretary of Health and 
Human Services determines is appropriate.  These trainings can be found from organizations like 
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American Society of Addiction Medicine, American Academy of Addiction Psychiatry, 
American Psychiatry Association and many other professional healthcare organizations 
(SAMHSA, 2019).  Waived providers can treat 30 or 100 patients dependent on individual 
authorization from the Center for Substance Abuse Treatment (CSAT). 
  Healthcare facilities that offer MAT for opioid use disorder aim to reduce, eliminate and 
prevent opioid use and diversion in participating individuals.  Adherence to MAT therapy should 
improve patient survival, decrease illicit opiate use and other associated criminal activity and 
increase patients’ ability to gain/ maintain employment.  Ultimately, MAT strives to increase 
rates of successful, long-term recovery from opioid use disorder (SAMHSA, 2019).  
  Research shows that medication for opioid use disorder (MOUD) decreases the use of 
opioids in participating individuals and prevents opioid related deaths, criminal activity and 
infectious disease transmission (NIH, 2019).  Patients treated with assisted medications were also 
more likely to remain in therapy compared to patients receiving treatment that did not include 
medications (NIH, 2019).  A study conducted in 2017 showed that MOUD reduces the death rate 
among individuals with opioid use disorder by 50% (Sordo et al., 2017).  Major organizations 
such as, the Food and Drug Administration, World Health Organization, the Substance Abuse 
and Mental Health Services Administration, the Surgeon General and American Medical 
Association all endorse MOUD and report that these therapies can prevent relapses and fatal 
overdoses (Shatterproof, 2019).  
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CHAPTER 3: EVIDENCE SUPPORTING CLINICAL PROBLEM 
Search Strategy  
 Databases used to review the literature included, PUBMED and CINAHL. Search query 
used: (“Rural Providers”[Mesh] OR “MAT inequities” OR MAT disparities) retrieved 97 items, 
and (“Opioid abuse” [Mesh] OR “Opioid Misuse” OR “Opioid Use”) retrieved 7,271 items.  The 
combination of (“Rural Providers”[Mesh] OR “MAT inequities” OR MAT disparities) AND 
(“Opioid abuse” [Mesh] OR “Opioid Misuse” OR “Opioid Use”) retrieved 10 items.  The 
following search retrieved articles useful for program evaluation related to opioid abuse 
treatment: ("Program Evaluation"[Mesh] OR "program evaluation" OR "program assessment") 
retrieved 77,635 items and  ("Opiate Substitution Treatment"[Mesh] OR "Opiate Substitution 
Treatment"[tiab] OR "Medication-Assisted Treatment") retrieved 3,079 items.  The combination 
of ("Program Evaluation"[Mesh] OR "program evaluation" OR "program assessment") AND and  
("Opiate Substitution Treatment"[Mesh] OR "Opiate Substitution Treatment"[tiab] OR 
"Medication-Assisted Treatment") retrieved 58 items.  Word combinations of, “MAT 
inequities”, “Medication-assisted treatment”, “MAT program evaluations”, “opioid abuse”, 
“opioid misuse”, “rural providers with MAT waiver”, “rural providers”, were used in the 
database with “AND” or “OR” to review the literature.  Finding articles on program evaluations 
of  MAT therapy courses offered to providers  in rural communities provided no results.  Most 
searches provided studies on MAT therapy in rural communities or exclusively program 
evaluations of MAT programs.  Delimiters included: articles that were not pertaining to opioid 
abuse, misuse or addiction, studies that did not take place in the United States; and articles that 
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were not in English.  The years searched were from 2014-2019, the majority of the literature 
reviewed included articles that were published within the past two years.  After thoroughly 
reviewing the literature 15 articles were selected.  
Study and Sample Characteristics 
 The strength of the body of evidence was low, possibly very low according to the 
GRADE standard (Balshem et al., 2011).  Few high GRADE, level I or II studies exist on topics 
pertaining to MAT in rural communities, program evaluations and interventions to increase rural 
MAT providers.  The majority of evidence was descriptive empirical research, qualitative 
research designs, questionnaires, qualitative evaluation designs and expert opinions, levels VI 
and VII.  The systematic review (Jumah, 2016) and a retrospective cohort design (Cole et al., 
2019) were the highest quality, Level I and II.  Significant bias was a limitation due to study 
design (Andrilla et al., 2018; Andrilla, Moore, Patterson & Larson, 2019; Deflavio, Rolin, 
Nordstrom & Kazal, 2015; Donohue, 2019; Rieckmann, Moore, Croy, Aarons & Novins, 2017; 
Salvador et al., 2019; Scott et al., 2019; Sigmon, 2014 & Santoro, Santoro, 2019).  The sample to 
support the lack of providers with MAT in rural communities consisted of 11,793 participants 
(Jumah, 2016; Andrilla et al., 2018; Rieckmann et al., 2017; Jones, 2018; Sigmon, 2014).  All of 
the studies were conducted in the United States, except for Jumah (2016) which gathered data 
from the United States, Canada and Australia.  
Results and Outcomes 
 Ten of the 15 studies reviewed supported a substantial disparity between rural and urban 
counties (Jumah, 2016; Andrilla et al., 2018; Andrilla et al., 2019; Lagisetty, Ross & Bohnert, 
2019; Moore, Andrilla & Patterson, 2019; Hutchinson et al., 2014; Rieckmann et al., 2017; 
Jones, 2018; Sigmon, 2014; Santoro, Santoro, 2018).  Rural communities experience greater 
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barriers to receiving MAT and increased opioid overdose rates than their urban counterparts. 
(Jumah, 2016; Andrilla et al., 2018; Rieckmann, 2017; Jones, 2018; Sigmon, 2014; Cole et al., 
2019; Deflavio et al., 2015; Santoro, Santoro, 2018).  Despite the increase of MAT across 
geographic categories within the U.S., 56.3% of rural counties still lack a waivered physician. 
Almost 20 million Americans reside in a county without a waivered physician, with the majority 
of them (67.7%) being in rural areas (Andrilla et al., 2019). Rural non-white minority death rates 
have significantly increased over the past 15 years, especially in the young adult population 
(Andrilla, 2018; Santoro, Santoro, 2018).  One of the most significant obstacles facing rural 
American minority groups in opioid use treatment is limited access to providers who can assist 
with MAT (Jumah, 2016; Rieckmann et al., 2017; Santoro, Santoro, 2018).  One-in- four health 
centers offer substance use treatment and specifically buprenorphine prescribers compared to 
urban health centers, which is particular concern because rural patients have few alternative 
options for MAT (Jones, 2018).  Additionally, non- government funded MAT clinics are more 
frequently used in high income areas, which results in even less access to care for minorities who 
live in rural low socioeconomic areas. (Jumah, 2016; Rieckmann et al., 2017; Santoro, Santoro, 
2018). 
 Expanding the number of clinicians nationwide who possess a MAT waiver to prescribe 
buprenorphine is a key recommendation to improve access to MAT for individuals with opioid 
use disorder (Andrilla 2018; Andrilla, 2019; Cole et al., 2019; Deflavio, 2015).  Much of the 
opioid epidemic is located in rural and historically marginalized communities, and many of these 
communities lack a single provider with a MAT waiver (Andrilla, 2018; Andrilla; 2019; Jumah, 
2016; Rieckmann et al., 2017).  To further compound the problem, more than half of rural 
providers with MAT waivers are not actually treating patients (Andrilla, 2018; Hutchinson et al., 
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2014; Moore et al., 2019; Moore, 2019).  Many  providers experience resistance from clinical 
managers or larger organizations which advise them to refrain from providing MOUD because it 
necessitates subspecialty backup or psychosocial services (Andrilla, 2019 & Moore, 2019).  The 
most common barriers to using MAT waivers among providers were concerns about diversion, 
inadequate reimbursement, stigma around patients with SUDs and lack of appropriate support 
services within the community (Andrilla, 2018; Deflavio et al., 2015; Jones, 2018; Hutchinson et 
al., 2014; Moore et al., 2019; Sigmon, 2014).  Along with the lack of  provider utilization of 
waivers, few rural waivered providers are accepting new patients, which further diminishes 
access to treatment (Andrilla, 2018; Andrilla 2019, Hutchinson et al., 2014; Moore et al., 2019, 
Moore, 2019).  Also, regulations exist on the quantity of patients a waivered provider can treat 
with buprenorphine, which creates another barrier to treatment.  Waivered providers meet their 
capacity for prescribing MOUDs resulting in lengthy waitlists for patients seeking treatment.  
When patients remain on long waitlists they are at risk for increased illicit drug use, overdose, 
criminal activity, infectious disease and mortality (Andrilla, 2019, Sigmon, 2014).  The shortage 
of treatment options in rural areas has placed barriers on individuals with opioid use disorder 
who must travel to access MAT.  Many individuals seeking MAT lack a driver’s license and rely 
on public transportation or family and friends to take them to appointments (Cole et al., 2019; 
Jones, 2018; Sigmon, 2014).  The difficulty involved with transportation alone is enough to 
discourage patients from attending their appointments to receive MAT.   
 In an effort to increase providers with MAT waivers, the Comprehensive Addiction and 
Recovery Act expanded buprenorphine prescribing rights to nurse practitioners and physician 
assistants with a cap of 30 patients (Sigmon, 2014; Moore, 2019 ).  Despite allowing nurse 
practitioners and physician assistants to obtain MAT waivers in order to increase access to care, 
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barriers still exist.  Most insurance companies will not reimburse services that are not overseen 
by a licensed physician.  Many providers report that their reimbursement rate was too low given 
the time required to treat patients using MAT(Sigmon, 2014; Rieckmann et al., 2017; Moore et 
al., 2019, Moore, 2019).  In 28 states, waivered nurse practitioners must be supervised by a MAT 
waivered physician in order to prescribe buprenorphine, which creates a barrier for patients and 
nurse practitioners because the number of waivered physicians in rural areas is low (Andrilla et 
al., 2019; Moore, 2019; Jumah, 2016; Rieckmann et al., 2017).  Due to the recent adoption of the 
Comprehensive Addiction and Recovery Act in 2016, there are limited studies on the 
effectiveness nurse practitioners and physician assistants have on expanding access to care in 
rural communities.  The Comprehensive Addiction and  Recovery Act has increased the number 
of buprenorphine providers, but barriers for providing MAT in rural communities still exist for 
nurse practitioners and physician assistants (Sigmon, 2014; Andrilla et al., 2019; Moore, 2019).  
 Substance use programs serving historically marginalized communities are at a 
substantially lower rate than MAT treating the general population (Andrilla, 2018; Lagisetty et 
al., 2019; Rieckmann et al., 2017).   Research findings report limited substance use programs in 
minority rural communities implement MAT and these communities have higher rates of 
substance use than urban predominantly Caucasian communities (Jumah, 2016; Lagisetty et 
al.,2019; Rieckmann et al., 2017; Andrilla 2018).  Buprenorphine treatment is concentrated 
among urban communities and Caucasian individuals with private insurance, even though rural 
minority populations are affected more by opioid use disorder.  Also, buprenorphine 
prescriptions are given at a considerably higher rate to white patients than other ethnicities 
(Jumah, 2016; Lagisetty et al.,2019; Rieckmann et al., 2017; Santoro, Santoro, 2018).  There is 
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an increase in opioid use in rural historically marginalized communities and the necessary means 
of treatment are not available to these populations.   
 Primary care providers report interest in obtaining MAT waivers to prescribe 
buprenorphine and believe having specialized support would increase their willingness to utilize 
their waiver (DeFlavio et al., 2015; Cole et al., 2019).  Many primary care providers evaluate 
patients with opioid use disorder and most feel a personal responsibility to provide MOUDs 
(DeFlavio et al., 2015; Cole et al., 2019).  Since there is an interest and sensed responsibility 
among primary care providers to help patients with opioid use disorder, increased awareness and 
increased MAT waiver trainings would allow primary care providers the potential to expand 
MAT access in rural communities.  Also, the Comprehensive Addiction and Recovery Act has 
allowed a significant increase in primary care providers in rural communities with MAT waivers; 
therefore, resulting in projections of increased number of patients with opioid use disorder 
receiving treatment by nurse practitioners and physician assistants (Sigmon, 2014; Moore, 2019).  
Rural residents with opioid use visit their primary care provider a few times a year, which means 
individuals with opioid use disorder have adequate contact with primary care providers, thereby 
facilitating MAT intervention (Donohue, 2019; DeFlavio et al., 2015).  
 Recent advances in mobile health technologies such as Project ECHO® provide 
education and patient care beyond the confines of a medical office.  This is a promising approach 
of using technological systems off low cost, expanded access and availability, and consistency in 
patient care and convenience (Sigmin, 2014; Komaromy, 2016; Salvador et al., 2019).  Project 
ECHO® provides MAT training to primary care providers  in an attempt to expand access of 
MAT services to rural communities.  Providers who engage in ECHO® sessions to achieve the 
necessary hours needed to obtain a MAT waiver emphasized the ease of access to the virtual 
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sessions, the expert engagement opportunity, and the didactic interactive presentations 
(Komaromy, 2016; Salvador et al., 2019).  The use of ECHO® interventions to address critical 
primary care trainings for physicians, physician assistants, and nurse practitioners to achieve 
MAT waivers is promising (Salvador, et al., 2019).  The use of Project ECHO® has shown many 
beneficial results that have helped increase the number of providers with MAT waivers and 
expansion of care through virtual capabilities. 
Summary 
 There is an established need for increased MAT providers in rural and historically 
marginalized communities.  The evidence supports lack of care for residents in these 
communities to enable recovery from illicit opioid use.  Lack of intervention in these 
communities enforces devastating results and increased mortality with proportionally higher 
rates in minority populations.  Primary care providers see many patients affected by opioid use, 
integrating MOUD into the primary care setting can expand access of care to underserved 
communities.  Mitigating the barriers that keep providers from obtaining MAT waivers, such as,  
utilizing Project ECHO®, can increase feasibility of obtaining the necessary education needed 
for providers to achieve a MAT waiver.  
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CHAPTER 4: THEORETICAL FRAMEWORK 
 The Kirkpatrick Model was used to objectively analyze the impact of the program.  This 
model provides a framework to understand participants learning experience and to create 
strategies to improve their learning in the future.  This model consists of four levels that provide 
a pragmatic and straightforward approach to the program evaluation process.  The model’s four 
levels of evaluation are built in a stair- step fashion and include (a) reaction, (b) learning, (c) 
behavior and (d) results (Kirkpatrick, 2016).  The first level of Kirkpatrick’s model focuses on 
participants’ reaction to the program.  Reactions equate to the participants overall satisfaction of 
the program.  Learning is the second level which measures the knowledge and skill acquired 
from their experience.  Evaluation on this level maybe through an interactive post- program case 
study or examination.  Behavioral data belongs to the third level of evaluation, which focuses on 
whether or how the participants will apply what they have learned into practice (Kirkpatrick, 
2016).  This level was an important piece of the evaluation because the aim is for participants to 
translate their knowledge and skill learned from this program into practice.  Lastly, the highest 
level of evaluation focuses on the results, which are obtained through data collection and 
synthesis (Kirkpatrick, 2016).  Assessment of education programs for healthcare professionals is 
vitally important for the future of healthcare. 
 This program evaluation supports the first two levels of Kirkpatrick’s Model, reaction 
and learning.  The initial piece of this program evaluation was to understand how the participants 
perceived or reacted to the training.  Topics addressed in the survey that apply to level one of 
Kirkpatrick’s model include understanding the objectives outlined in the course, having a clear 
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understanding of what is expected of this program and understanding if the content learned is 
applicable to their current role.  Identifying if the participants understand the learning objectives 
and how it applies to their current situation provides great insight into the participant’s 
satisfaction of the program.  The initial perception and reaction of the program was an important 
piece of the evaluation process because it supplies the beginning evidence of the value of the 
program.  In Kirkpatrick’s Model, level two focuses on the degree to which the participants 
intend to apply their knowledge and skills in practice.  There are questions in the survey that seek 
to understand participants confidence, competence and comfort in utilizing their developed 
knowledge and skill into practice.  Along with evaluating confidence, it was also important to 
evaluate their intention or willingness to utilize their learned experience into practice.  In the 
survey there were questions developed to specifically assess their intention and confidence in 
applying their learned knowledge into their role as a future provider.   
 The third and fourth level of Kirkpatrick’s model was not assessed in this particular 
program evaluation because the actions of the participants upon completing the program were 
not assessed.  The primary goal of this program evaluation was to determine if participants had 
an increased interest in learning more about becoming a MAT waivered provider and if they had 
an increased interest to serve historically marginalized communities.  The evaluation and result 
levels of Kirkpatrick’s model go beyond evaluating the participants’ intentions and willingness 
to actually assessing the changed behavior taking place.  Testing at this level requires following 
the participants into their role or workplace to witness how and if they utilize their learned 
knowledge and skills.  These were important factors to be measured and will occur through a 
separate evaluation by the state-funded evaluation team.  This team sent a 90-day post training 
practice survey to the participants to evaluate their changed practice behavior. 
 
16 
CHAPTER 5: PROJECT DESIGN 
 This quality improvement project was achieved through a scholarly formative program 
evaluation.  The purpose of a formative evaluation is to systematically gather information and 
data from the newly developed program to identify measures to be improved and to identify if 
the aim of the program was accomplished (CDC, 2020).  Formative evaluations are useful for 
analyzing novel learning materials, acquired student learning and instructional effectiveness. 
Analyzing these measures will help to identify program needs, improvement methods and 
justification of ways the objectives and goals were met (CDC, 2020).  This evaluation is external, 
which means the program assessment was conducted by someone from outside the organization. 
This approach has the capacity to have higher objectivity, increased freedom to identify 
problems and expertise in conduction of a thorough comprehensive evaluation (Barrett, 2015).  
 In this novel program, research is translated from the literature into an educational class 
that informs providers about the inequities related to MAT in rural and historically marginalized 
communities.  This program evaluation makes an important contribution to the clinical body of 
knowledge by helping to identify means of improvement and will be achievable through the 
available resources and data MAHEC will disclose.  Promoting Equity in the Management of 
Substance Use Disorders program strives to educate student providers on the status of 
historically marginalized communities and their intersection with opioid use treatment (MAHEC, 
2020). The students attend a 90-minute didactic session where they learn about status historically 
marginalized communities and examine power, bias, stigma and how privilege impacts substance 
use treatment. The students also learn how social and structural determinants of health impact 
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individuals with SUD and how to promote equitable and inclusive care. A 30-minute debrief 
session is held after the didactic session to explore how to embed equity and apply lessons 
learned into practice. This program offers technical assistance opportunities for practice 
transformation and an Accountability for Practice Change document which serves as a written 
plan on how to operationalize embedding equity in the management of SUD. 
Setting and Resources 
 Mountain Area Health Education Center is one of the nine educational centers in the 
North Carolina Area Health Education Center Program (NC AHEC) and serves the western part 
of North Carolina.  To help improve the training and retention of healthcare professionals across 
Western North Carolina, MAHEC offers specialized trainings, curriculums and mentorships to 
healthcare professionals and students in healthcare programs (MAHEC, 2020).  
 Residency and fellowship programs are offered to train healthcare professionals and 
students in healthcare curriculums to provide evidence-based patient-centered healthcare 
(MAHEC,2020).  In efforts to combat the opioid epidemic and sustainably embed MAT 
education into provider curriculums in North Carolina, MAHEC created The MAT Training 
Project. This project offers several different continuing education trainings for existing providers 
and student providers. These trainings include: MAT Waiver Training, Treating Pain Safely, 
MAT 101 Training, SUD 101 for the Clinic Team and Tapering Opioids for Chronic Pain. The 
MAT Training Project also offers a technical assistance package to support MAT/MOUD 
practices. This includes, MAT/ MOUD curriculum development blueprints, shadowing 
opportunities and Project ECHO®. Promoting Equity in the Management of Substance Use 
Disorders is a new pilot continuing education training offered through the MAT Training Project 
that specifically provides education on the health inequities experienced by historically 
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marginalized communities and how the healthcare system can improve to meet the needs 
(MAHEC, 2020).  The content in this program was developed by a multidisciplinary team led by 
two MAHEC Medical Co-directors. This pilot intervention was offered to residents at three 
Family Medicine sites. There were three designated faculty champions who led the 90 minute 
didactic portion and four resident champions who led the 30 minute debrief portion. After the 
didactic and debrief sessions, resident champions at each of these Family Medicine sites had the 
opportunity to connect with MAHEC’s Medical Co-directors to create a plan on how to 
operationalize the process of embedding equity into practice. The Medical Co-directors and 
resident champion champions reviewed an Accountability for Practice Change document which 
serves as a template to help strategically plan and operationalize embedding equity into their 
curriculums, policies and procedures. Afterwards, the resident champions submitted their 
Accountability for Practice Change document to their program’s leadership in order to encourage 
practice change.  
Key Stakeholders 
 The stakeholders involved in the program evaluation range from the participants, the 
universities where the program is offered and community members.  MAHEC takes particular 
interest in this program evaluation because they developed the North Carolina Medication- 
Assisted Treatment Training Project and will be offering this program to residents and advanced 
practicing students.  As a key stakeholder, MAHEC ensures that the right evaluation questions 
are developed and that the identified results will be used to make a difference (CDC, 2020).  The 
universities that allow the program to be offered to their students and faculty are other key 
stakeholders involved in this program evaluation.  Each of these organizations are invested in 
this program and believe their students and communities will benefit from increased MOUD 
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education.  These universities were responsible for hosting the program, thereby providing 
access to student providers.  The participants of this program are key stakeholders because they 
were the means to increasing MAT within North Carolina communities.  This program must 
captivate and educate the participants effectively to motivate them to help individuals suffering 
from opioid use disorder in vulnerable communities.  Lastly, the community members and 
clients being served and affected by MAT providers are also important stakeholders.  
Methods 
 This program was distributed and taught through an online platform.  Upon program 
completion a link to the developed post-survey questionnaire was provided to gather information 
from the participants.  This approach for data collection captured and quantified if there was 
increased provider willingness to serve historically marginalized communities and if they had an 
interest in learning more about how to become a waivered provider.  Quantitative data was 
collected through a structured survey that addresses the program outcomes.  This quantitative 
survey used closed- ended questions to help summarize large groups of responses with numerical 
coding (Bonnel, 2018).  In addition to the quantitative data, qualitative data was collected by a 
state- funded evaluation team as a part of the program evaluation.  The focus of MAHEC’s 
evaluation team was to understand the participants’ overall experience by obtaining qualitative 
data through interviews and surveys.  Both sets of qualitative and quantitative questions 
developed by the state-funded evaluation team and this program evaluation were combined into 
one post-survey questionnaire.  The comprehensive survey is seen in the appendix; however, 
questions 26, 27, 27a and 28 are only being analyzed for this study.  This questionnaire is based 
on a Likert scale.  
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Data Collection and Analysis 
 The primary outcome measures were if participants had an increased interest in learning 
more about becoming a MAT waivered provider and if they had an increased interest to serve 
historically marginalized communities.  Secondary outcomes were increased awareness of the 
limited mental health services in historically marginalized rural communities of North Carolina 
and an increased number of providers who intentionally want to embed equity when treating 
individuals with opioid use disorder.  These outcome measures were assessed after the 
participants completed the 90-minute didactic and 30-minute debrief session.  The online survey 
was distributed  though Survey Monkey (SurveyMonkey Inc.) and was be provided to 
participants through a link after they attend the online program. A follow-up email was sent from 
resident champions in order to encourage completion and response rate. Data analysis includes 
descriptive statistics from the information collected from the completed post-evaluation surveys.  
The collective data analysis from both evaluations is displayed in graphs to help identify 
patterns, trends or themes.  
Barriers to Implementation 
 When planning a program evaluation it is important to consider potential challenges and 
barriers that may affect the implementation process.  Adequate participant engagement was the 
most considerable and anticipated barrier to the implementation of this project. It is important to 
ensure adequate participation to effectively evaluate the measured outcomes.  Participation for 
this survey was not mandated, but was encouraged by MAHEC’s the program resident 
champions. The resident champions also had the specific role of being leaders and allies on the 
content as well as promoting and advertising the program to other students at the participating 
universities.  These resident champions ensured survey participation by follow-up emails and 
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providing the link to the survey. The resident champions the Intersection: Promoting Equity in 
the Management of Substance Use Disorders program were essential to overcoming the barrier 
of lack of adequate participation.  
Ethics and Human Subjects Permission 
 This program evaluation does not involve human subject experimentation or non- 
standard interventions.  The intent of this evaluation is to provide information about the program 
the participants are attending.  This program evaluation was reviewed for approval from the 
Institutional Review Board (IRB) at MAHEC.  
Results 
 Data analysis revealed all intended outcomes were met, as well as promising information 
into the future development and implementation of this program.  Data collection was obtained 
from the post- program distributed to all participants from the three North Carolina educational 
institutions March through August 2020. Unfortunately, the total response rate for the post 
surveys was lower than expected 60% (n=28).  The variation of participants ranged from faculty 
at the participating education facilities, residents and students from other disciplines. It is noted 
that no physician assistants or nurse practitioner students attended.  
 Results from the post- program survey demonstrated that 57 % of respondents (n= 16) 
strongly agree to have an increased interest in learning more about becoming MAT waivered.  
Moreover, 25% of respondents (n=7) modestly agree to have an increased interest in becoming 
MAT waivered and 18% of respondents (n=5) neither agreed nor disagreed to this statement. 
Historically marginalized communities and their intersection with substance use treatment was 
better understood by the majority of participants who completed the survey.  Subsequently, 39% 
of respondents (n= 11) strongly agreed that they had a better understanding of how marginalized 
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communities are affected by SUD and 57 % of respondents (n= 16) agreed to an increased 
understanding of these communities and their intersection with SUD. Only, one (4%) respondent 
neither agreed or disagreed with this statement.  In addition to increased understanding of how 
marginalized communities are affected by SUD, participants also gained an increased 
willingness and interest in helping individuals in marginalized communities who suffer from 
OUD.  Furthermore, 43% of respondents (n=12) strongly agreed to an increased interest in 
working with this community and 50% of respondents (n= 14) modestly agreed to increase 
interest in helping these underserved communities.  A small, 7 %  of respondents (n=2) neither 
agreed or disagreed to this question.  
 The free response question gained insight into which historically marginalized 
communities participants felt inspired to work with after completing the program.  This question 
yielded a variety of communities including: African American/ Black, Latinx, incarcerated/ 
formally incarcerated, Native American, individuals with SUD, LGBTQIA +, undocumented 
individuals, immigrants, Hispanic, rural and OUD communities.  There was a 75% (n=21) 
response rate for this free response question and 25% of participants (n=7) did not answer this 
question.  
Discussion 
 The primary aim of this project was to increase participants’ interest in becoming MAT 
waivered as well as increasing their interest in working in historically marginalized communities 
heavily impacted by SUD in North Carolina.  Intended secondary outcomes were to increase 
participants awareness and knowledge of the devastating affects SUD has on historically 
marginalized communities and the critical need for healthcare providers with MAT waivers. 
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Overall, the majority of participants modestly or strongly agreed to increased knowledge, 
awareness and interest in SUD in historically marginalized communities.  None of the 
participants modestly or strongly disagreed to any of the content addressed in the post-program, 
which implies each participant gained some insight or knowledge on how SUD and OUD 
intersects with vulnerable communities.  
 The survey question seeking to address if participants had an increased interest in 
learning more about becoming MAT waivered contained the highest rate of answers that fell into 
the neither agree or disagree category.  However, this particular question also had the highest 
answer rate of strongly agree by participants.  Interviewing the participants who neither agreed 
or disagreed to gaining an interest in becoming waivered maybe helpful for future modifications 
to the program.  Private interviews may also be helpful for the one participant who neither 
disagreed or agreed to having a better understanding of SUD and its intersection with historically 
marginalized communities and the two participants who neither disagreed or agreed to an 
increased interest in serving in these communities.  The post-program survey was anonymous, 
and participants may not want to be interviewed or may not have the allotted time to be 
interviewed.  An optional free-write section to each question may be helpful to gain insight into 
what factors or absence of factors lead to their selected answer.  
 After the training most participants became interested in working with historically 
marginalized communities.  The free-write question evaluated which specific communities 
participants felt inspired to work in and participants provided an array of answers. After this 
program, the majority of participants became interested in working with African American/ 
Black and Latinx communities.  Few participants mentioned Native American communities or 
rural communities, which are both underserved populations that desperately need more MAT 
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waivered providers.  Future trainings could provide additional information on specific Native 
American and rural communities in North Carolina severely affected by SUD.  Increasing 
awareness on the need of SUD treatment and specifically MAT waivered providers within these 
communities may increase participants willingness to work within these communities.  
 Seven out of the 28 participants did not answer this question.  However, only two 
participants neither agreed or disagreed to gaining an interest in working with marginalized 
communities.  This could mean that the seven participants likely had an interest in working with 
historically marginalized communities but were still deciding which particular community they 
wanted to work with.  
Limitations 
 Due to the COVID-19 pandemic, the entire program was converted to an online setting 
which prevented in-person engagement and interaction.  This likely impacted attendees’ level of 
attention to the material being discussed as well as attendance to the training.  There was a small 
sample size considering this program was available to all residents at three North Carolina 
educational institutes.  In addition to the small number of participants, there was an even smaller 
response rate to the post-program.  This small sample size affects the reliability and may lead to 
bias within the study.  
Recommendations  
 As mentioned, interviews or requested feedback to participants who selected disagree or 
neither agree or disagree may provide insight into potential program modifications.  Providing an 
optional free-write section to each question allows participants to elaborate on why they agreed 
or disagreed with the question, which may also provide valuable feedback to help with 
improvements to the program.  Encouraging faculty buy-in from participating educational 
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institutions could allow this training to be a component of required courses for resident, nurse 
practitioner and physician assistant students.  Also, gaining faculty champions from physician 
assistant and nurse practitioner programs along with resident champions can help increase 
participation rates within other disciplines. Physician assistants and nurse practitioners are key in 
providing substance use treatment and specifically, OUD care and bridging the gap in access to 
care. It is important for this program to be offered and advertised to physician assistant and nurse 
practitioner programs in addition to resident programs. This allows for an increased participant 
rate as well as an increased focus around equity for SUD in historically marginalized 
communities as a focus within resident, physician assistant and nurse practitioner curriculums.  
Conclusion 
 Despite national efforts to improve access to substance use disorder treatment and 
specifically opioid use disorder services, historically marginalized populations still do not 
receive adequate treatment.  Lack of culturally humble and responsive services, limited providers 
with MAT waivers, and scarcity of access to equitable care are all contributing factors to the 
persistent disparities in the treatment of SUD. Intersection: Promoting Equity in the Management 
of SUD program aims to educate future providers to ultimately increase the availability of 
equitable care for historically marginalized communities.  After training from this program most 
participants agreed and strongly agreed to increased knowledge on SUD and its intersection with 
marginalized communities, in addition to increased willingness to work in these vulnerable 
communities, and an increased interest to become MAT waived.  Considering future faculty buy-
in from the participating universities allows for potential dissemination throughout resident, 
physician assistant and nurse practitioner programs.  Incorporating this program into course 
curriculums or requiring student providers to participate in this program will increase health 
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equity awareness and efforts. If future providers are willing and able to promote equitable and 
inclusive care to patients with SUD and feel competent, confident and comfortable being an ally 
for individual with SUD there will be an increased workforce that implements equity into their 
clinical practice. This creates potential for increased patient access to care, improved patient-




APPENDIX A: POST SURVEY 
Intersection: Promoting Equity in the Management of Substance Use Disorders 
Post Survey 
 
1) I understand how bias can influence the clinical management of MOUDs. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
2) I have the skills to address bias in the clinical management of MOUDs. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
3) I intend to advocate against bias in the clinical management of MOUDs 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
4) My clinical site has the capacity to address bias in the clinical management of MOUDs. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
5) I understand how stigma can influence the clinical management of MOUDs. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
6) I have the skills to address stigma in the clinical management of MOUDs. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
7) I intend to advocate for a stigma-free MOUD clinical environment 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
8) My clinical site has the capacity to address stigma in the clinical management of MOUDs 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
9) I understand the importance of fostering inclusive therapeutic alliances with patients who have 
Opioid Use Disorder OUD 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
10) I have the skills to build inclusive therapeutic alliances with patients who have OUD. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
11) I intend to advocate for building inclusive therapeutic alliances with patients who have OUD. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
12) My clinical site places value on building inclusive therapeutic alliances with patients who 
have OUD. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
13) I understand the importance of implementing equitable healthcare practices with patients 
who have OUD. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
14) I have the skills to implement equitable healthcare practices with patients who have OUD 




15) I intend to advocate for implementing equitable healthcare practices with patients who have 
OUD. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
16) My clinical site implements equitable healthcare practices with patients who have OUD 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
17) I can identify situations in which forces such as prejudice, power, and privilege are involved. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
18) I know how to effectively manage situations in which forces such as prejudice, power, and 
privilege are involved. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
19) I understand the importance of allyship with patients who have OUD. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
20) I have the skills to be an effective ally with patients who have OUD. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
21) I am confident in my ability to be an ally to my colleagues. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
22) I am confident in my ability to be an ally to team members/ staff. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
23) My clinical site promotes equity, diversity, inclusivity, and belonging 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
24) Health equity considerations are integrated into our program’s MAT curriculum. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
25) I will be able to apply or integrate health equity considerations into my clinical site. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
26) I have an interest in learning more about becoming a MAT-waivered provider. 
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
27) I have an increased interest in helping individuals with substance use disorder who are from 
historically marginalized communities.  
Strongly Disagree   Disagree   Neutral   Agree Strongly  Agree  
 
 27a) Which historically marginalized communities do you feel interested in working 
 with? (Free text) 
 
28) I have a better understanding of the status of historically marginalized communities and their 
intersection with substance abuse treatment. 





APPENDIX B: GRAPHS 
 
Figure 1.  MAT Waivered 
 
 














I have a better understanding of the status 
of historically marginalized communities 









Figure 3.  Helping Individuals with Substance Abuse Disorder 
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Figure 5.  Post Survey Completion Rate 
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